Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.

Hosseini MM, Kurtz SE, Abdelhamed S, Mahmood S, Davare MA, Kaempf A, Elferich J, McDermott JE, Liu T, Payne SH, Shinde U, Rodland KD, Mori M, Druker BJ, Singer JW, Agarwal A.

Leukemia. 2018 Mar 29. doi: 10.1038/s41375-018-0112-2. [Epub ahead of print]

PMID:
29743719
2.

Retrospective screening of microarray data to identify candidate IFN-inducible genes in a HTLV-1 transformed model.

Refaat A, Owis M, Abdelhamed S, Saiki I, Sakurai H.

Oncol Lett. 2018 Apr;15(4):4753-4758. doi: 10.3892/ol.2018.8014. Epub 2018 Feb 9.

3.

Extracellular vesicles in the hematopoietic microenvironment.

Butler JT, Abdelhamed S, Kurre P.

Haematologica. 2018 Mar;103(3):382-394. doi: 10.3324/haematol.2017.183335. Epub 2018 Feb 8. Review.

4.

AKT-STAT3 Pathway as a Downstream Target of EGFR Signaling to Regulate PD-L1 Expression on NSCLC cells.

Abdelhamed S, Ogura K, Yokoyama S, Saiki I, Hayakawa Y.

J Cancer. 2016 Jul 18;7(12):1579-1586. eCollection 2016.

5.

AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB.

Hornick NI, Doron B, Abdelhamed S, Huan J, Harrington CA, Shen R, Cambronne XA, Chakkaramakkil Verghese S, Kurre P.

Sci Signal. 2016 Sep 6;9(444):ra88. doi: 10.1126/scisignal.aaf2797.

PMID:
27601730
6.

Targeting the ataxia telangiectasia mutated pathway for effective therapy against hirsutine-resistant breast cancer cells.

Lou C, Yokoyama S, Abdelhamed S, Saiki I, Hayakawa Y.

Oncol Lett. 2016 Jul;12(1):295-300. Epub 2016 May 11.

8.

Hope and hype surrounding circulating microRNA as potential next generation AML biomarkers.

Abdelhamed S, Kurre P.

Leuk Res. 2015 Dec;39(12):1309-11. doi: 10.1016/j.leukres.2015.09.018. Epub 2015 Sep 21. No abstract available.

PMID:
26602021
9.

Role of tyrosine kinase-independent phosphorylation of EGFR with activating mutation in cisplatin-treated lung cancer cells.

Refaat A, Aminullah, Zhou Y, Kawanishi M, Tomaru R, Abdelhamed S, Shin MS, Koizumi K, Yokoyama S, Saiki I, Sakurai H.

Biochem Biophys Res Commun. 2015 Mar 20;458(4):856-61. doi: 10.1016/j.bbrc.2015.02.044. Epub 2015 Feb 18.

PMID:
25701783
10.

Survivin suppression through STAT3/β-catenin is essential for resveratrol-induced melanoma apoptosis.

Habibie, Yokoyama S, Abdelhamed S, Awale S, Sakurai H, Hayakawa Y, Saiki I.

Int J Oncol. 2014 Aug;45(2):895-901.

PMID:
24946930
11.

Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.

Abdelhamed S, Yokoyama S, Refaat A, Ogura K, Yagita H, Awale S, Saiki I.

Anticancer Res. 2014 Apr;34(4):1893-9.

PMID:
24692724
12.

Berberine enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast cancer.

Refaat A, Abdelhamed S, Yagita H, Inoue H, Yokoyama S, Hayakawa Y, Saiki I.

Oncol Lett. 2013 Sep;6(3):840-844. Epub 2013 Jul 1.

13.

A flavonoid chrysin suppresses hypoxic survival and metastatic growth of mouse breast cancer cells.

Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Maruyama T, Athikomkulchai S, Viriyaroj A, Awale S, Yagita H, Ruchirawat S, Svasti J, Saiki I.

Oncol Rep. 2013 Nov;30(5):2357-64. doi: 10.3892/or.2013.2667. Epub 2013 Aug 20.

PMID:
23969634
14.

Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation.

Lirdprapamongkol K, Sakurai H, Abdelhamed S, Yokoyama S, Athikomkulchai S, Viriyaroj A, Awale S, Ruchirawat S, Svasti J, Saiki I.

Int J Oncol. 2013 Jul;43(1):329-37. doi: 10.3892/ijo.2013.1926. Epub 2013 May 1.

PMID:
23636231
15.

Identification of plant extracts sensitizing breast cancer cells to TRAIL.

Abdelhamed S, Yokoyama S, Hafiyani L, Kalauni SK, Hayakawa Y, Awale S, Saiki I.

Oncol Rep. 2013 May;29(5):1991-8. doi: 10.3892/or.2013.2293. Epub 2013 Feb 19.

PMID:
23426404
16.

Uvaridacols E-H, highly oxygenated antiausterity agents from Uvaria dac.

Awale S, Ueda JY, Athikomkulchai S, Dibwe DF, Abdelhamed S, Yokoyama S, Saiki I, Miyatake R.

J Nat Prod. 2012 Nov 26;75(11):1999-2002. doi: 10.1021/np300596c. Epub 2012 Oct 23.

PMID:
23092429
17.

Antiausterity agents from Uvaria dac and their preferential cytotoxic activity against human pancreatic cancer cell lines in a nutrient-deprived condition.

Awale S, Ueda JY, Athikomkulchai S, Abdelhamed S, Yokoyama S, Saiki I, Miyatake R.

J Nat Prod. 2012 Jun 22;75(6):1177-83. doi: 10.1021/np300295h. Epub 2012 Jun 7.

PMID:
22676269

Supplemental Content

Loading ...
Support Center